These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2459396)

  • 1. Detecting distant homologies of mosaic proteins. Analysis of the sequences of thrombomodulin, thrombospondin complement components C9, C8 alpha and C8 beta, vitronectin and plasma cell membrane glycoprotein PC-1.
    Patthy L
    J Mol Biol; 1988 Aug; 202(4):689-96. PubMed ID: 2459396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense sequences of 20-kDa homologous restriction factor (HRF20) are found in C9 and the C8 beta chain of homologous complement.
    Campbell W; Baranyi L; Okada N; Okada H
    Antisense Res Dev; 1993; 3(3):291-4. PubMed ID: 7506958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
    Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
    Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.
    Scibek JJ; Plumb ME; Sodetz JM
    Biochemistry; 2002 Dec; 41(49):14546-51. PubMed ID: 12463754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural homology of complement protein C6 with other channel-forming proteins of complement.
    Chakravarti DN; Chakravarti B; Parra CA; Muller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2799-803. PubMed ID: 2468158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J; Mollnes TE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary DNA and derived amino acid sequence of the beta subunit of human complement protein C8: identification of a close structural and ancestral relationship to the alpha subunit and C9.
    Howard OM; Rao AG; Sodetz JM
    Biochemistry; 1987 Jun; 26(12):3565-70. PubMed ID: 2820472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T; Morgan BP; Meri S
    Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.
    Musingarimi P; Plumb ME; Sodetz JM
    Biochemistry; 2002 Sep; 41(37):11255-60. PubMed ID: 12220191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8 alpha by homologous restriction factor (CD59).
    White RV; Kaufman KM; Letson CS; Platteborze PL; Sodetz JM
    J Immunol; 1994 Mar; 152(5):2501-8. PubMed ID: 7510745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary DNA cloning of complement C8 beta and its sequence homology to C9.
    Haefliger JA; Tschopp J; Nardelli D; Wahli W; Kocher HP; Tosi M; Stanley KK
    Biochemistry; 1987 Jun; 26(12):3551-6. PubMed ID: 3651397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
    Zalman LS; Wood LM; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region.
    Plumb ME; Scibek JJ; Barber TD; Dunlap RJ; Platteborze PL; Sodetz JM
    Biochemistry; 1999 Jun; 38(26):8478-84. PubMed ID: 10387094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
    Huang Y; Fedarovich A; Tomlinson S; Davies C
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.